Targeting cancer-intrinsic protein neddylation bypasses the loss of JAK/STAT signaling and overcomes acquired resistance to immunotherapy.
- DOI
- 10.21203/rs.3.rs-9107846/v1
- Published
- 2026 Aug 6
- Container
- Research square
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.21203/rs.3.rs-9107846/v1,
title = {Targeting cancer-intrinsic protein neddylation bypasses the loss of JAK/STAT signaling and overcomes acquired resistance to immunotherapy.},
author = {Mao Y and Bedos MR and Lu Y and Voutsinou E and Papakyriacou I and Alford L and Parracho R and Iyer V and Ribas A},
year = {2026},
journal = {Research square},
doi = {10.21203/rs.3.rs-9107846/v1},
url = {https://doi.org/10.21203/rs.3.rs-9107846/v1}
}RIS
TY - JOUR TI - Targeting cancer-intrinsic protein neddylation bypasses the loss of JAK/STAT signaling and overcomes acquired resistance to immunotherapy. AU - Mao Y AU - Bedos MR AU - Lu Y AU - Voutsinou E AU - Papakyriacou I AU - Alford L AU - Parracho R AU - Iyer V AU - Ribas A PY - 2026 JO - Research square DO - 10.21203/rs.3.rs-9107846/v1 UR - https://doi.org/10.21203/rs.3.rs-9107846/v1 ER -
APA
Y, M., MR, B., Y, L., E, V., I, P., L, A., R, P., V, I., & A, R. (2026). Targeting cancer-intrinsic protein neddylation bypasses the loss of JAK/STAT signaling and overcomes acquired resistance to immunotherapy.. Research square. https://doi.org/10.21203/rs.3.rs-9107846/v1
Source records
- pubmed · retrieved 2026-09-26T22:43:52.178Z
- europe-pmc · retrieved 2026-09-26T22:43:52.190Z